Former director at Privia Health Group Inc
- Value-based care and provider services industry trends and developments
- Capitation agreements and revenue model analysis, emphasising differences between “no upfront costs” and shared savings models
- Competitive landscape and key differentiations among Privia Health (NASDAQ: PRVA), Aledade, Agilon (NYSE: AGL) and others
- Potential M&A activities within the primary care sector, including likely buyers
- H2 2022 outlook and growth potential, including business risks, strategic assessments and threat of end-to-end offerings
Gain access to Premium Content
Submit your details to access up to 5 Forum Transcripts or to request a complimentary one week trial.